Skip to content
2000
Volume 20, Issue 2
  • ISSN: 1872-2083
  • E-ISSN: 2212-4012

Abstract

Imidazole and 2-mercapto benzimidazole analogues are a group of molecules that have various biological activities and good therapeutic potential in the treatment of epilepsy. This review explores their dual role, focusing on their biological properties and anti-epileptic effects. A spectrum of biological activities is displayed by imidazole derivatives and 2- mercaptobenzimidazole, such as antifungal, antioxidant, anti-inflammatory, and antimicrobial actions, leading to their therapeutic flexibility apart from epilepsy treatment. Imidazole derivatives mechanistically modulate Gamma-Aminobutyric Acid (GABA) receptors, inhibit ion channels, and exert neuroprotective effects, enabling them to be used for seizure control. Their mechanisms of action involve modulation of oxidative stress pathways as well as providing neuroprotective effects against epilepsy. In terms of structure, both imidazole and 2-mercaptobenzimidazole derivatives have gone through extensive structure-activity relationship studies to enhance their biological and pharmacological aspects. However, numerous concerns, such as bioavailability, selectivity, and side effects, hinder their effective application in the treatment of various diseases. Looking forward, further research into novel derivatives and patented formulation strategies holds promise for enhancing efficacy and reducing adverse effects. This review consolidates current knowledge, emphasizing the multifaceted roles of imidazole and 2-mercapto benzimidazole derivatives in biological systems and their potential as anti-epileptic agents, thus providing insights for future research and clinical applications.

© 2026 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/biot/10.2174/0118722083345879250403115017
2025-04-25
2026-03-02

  • From This Site

    /content/journals/biot/10.2174/0118722083345879250403115017
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. GhoshS. SinhaJ.K. GhoshS. SharmaH. BhaskarR. NarayananK.B. A comprehensive review of emerging trends and innovative therapies in epilepsy management.Brain Sci.2023139130510.3390/brainsci13091305
     [Google Scholar]
  2. Corrales-HernándezM.G. Villarroel-HagemannS.K. Mendoza-RodeloI.E. Palacios-SánchezL. Gaviria-CarrilloM. Buitrago-RicaurteN. Development of antiepileptic drugs throughout history: From serendipity to artificial intelligence.Biomedicines2023116163210.3390/biomedicines11061632
     [Google Scholar]
  3. PanayiotopoulosC.P. Chapter 4, Principles of Therapy in Epilepsies. In: The Epilepsies: Seizures, Syndromes and Management.Oxfordshire, UKBladon Medical Publishing.2005 https://www.ncbi.nlm.nih.gov/books/NBK2607/
    [Google Scholar]
  4. EkL.S. Minimizing aed adverse effects: Improving quality of life in the interictal state in epilepsy care.Curr. Neuropharmacol.20097210610.2174/157015909788848857
     [Google Scholar]
  5. ParkM.K. KimE.S. Antiepileptic drug therapy in patients with drug-resistant epilepsy.J Epil Res201891142610.14581/jer.19002
     [Google Scholar]
  6. ShankarR. Prescribing anti-epileptic drugs for people with epilepsy and intellectual disability.2017Available from https://www.rcpsych.ac.uk/docs/default-source/improving-care/better-mh-policy/college-reports/college-report-cr206.pdf?sfvrsn=4db7a660
    [Google Scholar]
  7. RajagopalanK. CandrilliS.D. AjmeraM. Impact of antiepileptic-drug treatment burden on health-care-resource utilization and costs.Clinicoecon. Outcomes Res.20181061962710.2147/CEOR.S180913 30425541
     [Google Scholar]
  8. LucasA. RevellA. DavisK.A. Artificial intelligence in epilepsy applications and pathways to the clinic.Nat. Rev. Neurol.202420631933610.1038/s41582‑024‑00965‑9 38720105
     [Google Scholar]
  9. StanculescuG. Abstracts from the 26th international epilepsy congress. Epilepsia 2005;200546Suppl 63415
     [Google Scholar]
  10. YaseenG. SudhakarJ. Design, synthesis and antimicrobial activity of 2-mercaptobenzimidazole derivatives.Int J Pharm Bio Sci201014281286
     [Google Scholar]
  11. JuberK.I. Synthesis, characterization and biological evaluation of some 6-methoxy-2-mercaptobenzimida-] zole derivatives.Iraqi Nat J Chem201717216
     [Google Scholar]
  12. AlexanderR.P. BentleyJ.M. BraceG.N. BrookingsD.C. ChovatiaP.T. DebovesH.J. JohnstoneC. JonesE.P. KroeplienB. LecomteF.C. MaddenJ. Brookings DC, Chovatia PT, Deboves HJ, Johnstone C, Jones EP, Kroeplien B, Lecomte FC, Madden J. Fused imidazole and pyrazole derivatives as modulators of TNF activity.US Patent 9868749B22018
  13. NikhilaG.R. BatakurkiS.R. YallurB.C. Synthesis, characterization and antioxidant studies of benzo[4,5]imidazo[2,1-b]thiazole derivatives.AIP Conference Proceedings202022741050017
     [Google Scholar]
  14. RossiR. CiofaloM. An updated review on the synthesis and antibacterial activity of molecular hybrids and conjugates bearing imidazole moiety.Molecules20202521513310.3390/molecules25215133
     [Google Scholar]
  15. VermaBK KapoorS KumarU PandeyS AryaP Synthesis of new imidazole derivatives as effective antimicrobial agents. Indian J Pharm Biol Res2017511910.30750/ijpbr.5.1.1
     [Google Scholar]
  16. GujjarappaR. KabiA.K. SravaniS. GargA. VodnalaN. TyagiU. Overview on biological activities of imidazole derivatives. Nanostructured Biomaterials Materials Horizons: From Nature to Nanomaterials. Swain BP.SingaporeSpringer202213522710.1007/978‑981‑16‑8399‑2_6
     [Google Scholar]
  17. Álvarez-MartínezF.J. Barrajón-CatalánE. Herranz-LópezM. MicolV. Antibacterial plant compounds, extracts and essential oils: An updated review on their effects and putative mechanisms of action.Phytomedicine202190153626
     [Google Scholar]
  18. LiuG.C. GreenS.I. MinL. Phage-antibiotic synergy is driven by a unique combination of antibacterial mechanism of action and stoichiometry.MBio2020114e01462e2010.1128/mBio.01462‑20 32753497
     [Google Scholar]
  19. QiD. ZouL. ZhouD. ChenY. GaoZ. FengR. Taxonomy and broad-spectrum antifungal activity of streptomycessp. SCA3-4 isolated from rhizosphere soil of Opuntia stricta.Front. Microbiol.201910139010.3389/fmicb.2019.01390
     [Google Scholar]
  20. LiT. LiL. DuF. SunL. ShiJ. LongM. Activity and mechanism of action of antifungal peptides from microorganisms: A review.Molecules MDPI AG20212611343810.3390/molecules26113438
     [Google Scholar]
  21. PippiB. LopesW. ReginattoP. New insights into the mechanism of antifungal action of 8-hydroxyquinolines.Saudi Pharm. J.2019271414810.1016/j.jsps.2018.07.017 30662305
     [Google Scholar]
  22. ArmengolS.E. HarmanciM. LaffleurF. Current strategies to determine antifungal and antimicrobial activity of natural compounds.Microbiol. Res.202125212686710.1016/j.micres.2021.126867
     [Google Scholar]
  23. NazzaroF. FratianniF. CoppolaR. FeoD.V. Essential oils and antifungal activity.Pharmaceuticals20171048610.3390/ph10040086
     [Google Scholar]
  24. RenziDF Campos AdL, Miranda EH, et al Nanoparticles as a tool for broadening antifungal activities.Curr. Med. Chem.20212891841187310.2174/0929867327666200330143338 32223729
     [Google Scholar]
  25. NicolaM.A. AlbuquerqueP. PaesC.H. FernandesL. CostaF.F. KioshimaS.E. Antifungal drugs: New insights in research & development.Pharmacol. Ther.2019195213810.1016/j.pharmthera.2018.10.008
     [Google Scholar]
  26. AkinwumiB.C. BordunK.A.M. AndersonH.D. Biological activities of stilbenoids.Int. J. Mol. Sci.201819379210.3390/ijms19030792
     [Google Scholar]
  27. KimS. Competitive biological activities of chitosan and its derivatives: Antimicrobial, antioxidant, anticancer, and anti-inflammatory activities.Int. J. Polym. Sci.201820181170817210.1155/2018/1708172
     [Google Scholar]
  28. BenkhairaN. KoraichiS.I. Fikri-BenbrahimK. In vitro methods to study antioxidant and some biological activities of essential oils: A review.Biointerf Res. Appl. Chem.202212333323347
     [Google Scholar]
  29. JucáM.M. FilhoC.F.M.S. Almeida dJC. Flavonoids: Biological activities and therapeutic potential.Nat. Prod. Res.202034569270510.1080/14786419.2018.1493588
     [Google Scholar]
  30. PrithvirajK. Biological activities of flavonoids: An overview.Inter J. Pharma Sci. Res.201910415671574
     [Google Scholar]
  31. AlghamdiS.S. SulimanR.S. AlmutairiK. KahtaniK. AljatliD. Imidazole as a promising medicinal scaffold: Current status and future direction.Drug Des. Devel. Ther.2021153289331210.2147/DDDT.S307113
     [Google Scholar]
  32. AliE.M.H. Abdel-MaksoudM.S. HassanR.M. Design, synthesis and anti-inflammatory activity of imidazol-5-yl pyridine derivatives as p38α/MAPK14 inhibitor.Bioorg. Med. Chem.20213111596910.1016/j.bmc.2020.115969 33422910
     [Google Scholar]
  33. ShankarB. JalapathiP. ValeruA. KumarK.A. SaikrishnaB. KudleK. Synthesis and biological evaluation of new 2-(6-alkyl-pyrazin-2-yl)-1H-benz[d]imidazoles as potent anti-inflammatory and antioxidant agents.Med. Chem. Res.20172691835184610.1007/s00044‑017‑1897‑7
     [Google Scholar]
  34. SangeethaK.S. UmamaheswariS. ReddyC.U. KalkuraS.N. Flavonoids: Therapeutic potential of natural pharmacological agents.Int. J. Pharm. Sci. Res.20167103924
     [Google Scholar]
  35. RochaT.M. MachadoN.J. SousaD.J.A.C. Imidazole alkaloids inhibit the pro-inflammatory mechanisms of human neutrophil and exhibit anti-inflammatory properties in vivo.J. Pharm. Pharmacol.201971584985910.1111/jphp.13068 30652314
     [Google Scholar]
  36. JhaM. AlamO. NaimM.J. SharmaV. BhatiaP. SheikhA.A. Recent advancement in the discovery and development of anti-epileptic biomolecules: An insight into structure activity relationship and Docking.Eur. J. Pharm. Sci.2020153289331210.2147/DDDT.S307113
     [Google Scholar]
  37. Al-OtaibiF. An overview of structurally diversified anticonvulsant agents.Acta Pharm.201969332134410.2478/acph‑2019‑0023
     [Google Scholar]
  38. JankovićS.M. DješevićM. JankovićS.V. Experimental GABA a receptor agonists and allosteric modulators for the treatment of focal epilepsy.J. Exp. Pharmacol.20211323524410.2147/JEP.S242964
     [Google Scholar]
  39. GreenfieldL.J. Molecular mechanisms of antiseizure drug activity at GABAA receptors.Seizure201322858960010.1016/j.seizure.2013.04.015
     [Google Scholar]
  40. MatiasM. SilvestreS. FalcaoA. GilbertoA. Recent highlights on molecular hybrids potentially useful in central nervous system disorders.Mini Rev. Med. Chem.201717648651710.2174/1389557517666161111110121
     [Google Scholar]
  41. CzapińskiP. BlaszczykB. CzuczwarS. Mechanisms of action of antiepileptic drugs.Curr. Top. Med. Chem.20055131410.2174/1568026053386962 15638774
     [Google Scholar]
  42. LondheO.A. BhorR.J. IngleP.S. ShahM.Z.S. GadeD.R. GhogareR.D. Synthesis, characterization and in vivo biological activity of n-(2-chlorophenyl)-2-(2-methyl-5-nitro-1h-imidazol-1-yl) acetamide and its derivatives.J. Young Pharm.202416225226010.5530/jyp.2024.16.33
     [Google Scholar]
  43. SaganuwanS.A. Conversion of benzimidazoles, imidazothiazoles and imidazoles into more potent central nervous system acting drugs.Cent. Nerv. Syst. Agents Med. Chem.202020131210.2174/1871524919666190621160323 31223095
     [Google Scholar]
  44. Fluet-ChouinardA. Synthesis of analogs of a potential drug for treatment of Epilepsy [MSc thesis]. Ottawa, Canada: University of Ottawa; 201910.20381/ruor‑23505
     [Google Scholar]
  45. RaghuM.S. SwarupH.A. PrathibhaB.S. KumarK.Y. KumarC.B.P. AlhartiF.A. Design, synthesis and molecular docking studies of 5,6-difluoro-1H-benzo[d]imidazole derivatives as effective binders to GABA receptor with potent anticonvulsant activity.J. Mol. Struct.20231285135502
     [Google Scholar]
  46. EliewiA.G. Al-GarawiZ.S. Al-KazzazF.F. AtiaA.J.K. Multi target-directed imidazole derivatives for neurodegenerative diseases.J. Phys. Conf. Ser.20211853101206610.1088/1742‑6596/1853/1/012066
     [Google Scholar]
  47. PalR KumarB AkhtarJM ChawlaPA Bioorganic chemistry volume2021Available from: https://www.sciencedirect.com/science/article/abs/pii/S0045206821006076
    [Google Scholar]
  48. SongM.X. DengX.Q. Recent developments on triazole nucleus in anticonvulsant compounds: A review.J. Enzyme Inhib. Med. Chem.201833145347810.1080/14756366.2017.1423068
     [Google Scholar]
  49. KumarP. KapoorB. GuptaR. GuptaM. Imidazole: Chemistry and biological activities.Think India J20192237359380
     [Google Scholar]
  50. NuermbergerEL Preclinical efficacy testing of new drug candidates.Microbiol Spectr2017535.3.2410.1128/microbiolspec.TBTB2‑0034‑2017 28643624
     [Google Scholar]
  51. VilaJ. HebertA.A. TorreloA. LópezY. TatoM. García-CastilloM. Ozenoxacin: A review of preclinical and clinical efficacy.Expert Rev. Anti Infect. Ther.201917315916810.1080/14787210.2019.1573671
     [Google Scholar]
  52. PrickaertsJ. HeckmanP.R.A. BloklandA. Investigational phosphodiesterase inhibitors in phase I and phase II clinical trials for Alzheimer’s disease.Expert Opin. Investig. Drugs20172691033104810.1080/13543784.2017.1364360
     [Google Scholar]
  53. NairA. MorsyM.A. JacobS. Dose translation between laboratory animals and human in preclinical and clinical phases of drug development.Drug Dev. Res.201879837338210.1002/ddr.21461
     [Google Scholar]
  54. KanelidisA.J. PremerC. LopezJ. BalkanW. HareJ.M. Route of delivery modulates the efficacy of mesenchymal stem cell therapy for myocardial infarction: A meta-analysis of preclinical studies and clinical trials.Circ. Res.201712071139115010.1161/CIRCRESAHA.116.309819 28031416
     [Google Scholar]
  55. MacDonaldK.P.A. HillG.R. BlazarB.R. Chronic graft-versus-host disease: Biological insights from preclinical and clinical studies.Blood20171291132110.1182/blood‑2016‑06‑686618
     [Google Scholar]
  56. AlachkarA. AzimullahS. LotfyM. Antagonism of histamine H3 receptors alleviates pentylenetetrazole-induced kindling and associated memory deficits by mitigating oxidative stress, central neurotransmitters, and c-fos protein expression in rats.Molecules2020257157510.3390/molecules25071575 32235506
     [Google Scholar]
  57. BeleteT.M. Recent progress in the development of new antiepileptic drugs with novel targets.Ann. Neurosci.202330426227610.1177/09727531231185991
     [Google Scholar]
  58. LiG. Design and Synthesis of achiral and chiral imidazodiazepine (IMDZ) GABA(A)R subtype selective ligands for the treatment of CNS disorders as well as asthma [PhD dissertation]. Milwaukee, WI, USA: University of Wisconsin–Milwaukee;2019
     [Google Scholar]
  59. JahanR. Design and synthesis of novel drugs to treat Asthma by targeting GABAs receptor in lung: Design and synthesis of novel α2/α3 subtype GABAA ligands for drug design [PhD dissertation]. Milwaukee, WI, USA: University of Wisconsin–Milwaukee;2019
     [Google Scholar]
  60. MarvinM.G. Overview of drugs used for epilepsy and seizures.Pharm Therapeut2010357392415 20689626
     [Google Scholar]
  61. ZahnN.M. Development of new treatments for asthma and neuropathic pain based on γaminobutyric acid a receptor (GABAAR) ligands [PhD dissertation]. Milwaukee, WI, USA: University of Wisconsin– Milwaukee; 2022
     [Google Scholar]
  62. SubbaraoB.S. SilvermanA. Seizure medications continuing education activity.2023Available from https://www.ncbi.nlm.nih.gov/books/NBK482269/
    [Google Scholar]
  63. JiménezG.C.J. Chalcone-derived multitarget compounds for the treatment and diagnosis of neurodegenerative diseases.2023Available from https://docta.ucm.es/entities/publication/1d1ea4f4-1a3a-464e-a128-130479957810
    [Google Scholar]
  64. RizkM.L. BhavnaniS.M. DrusanoG. Considerations for dose selection and clinical pharmacokinetics/pharmacodynamics for the development of antibacterial agents.Antimicrob. Agents Chemother.2019635e02309e0231810.1128/AAC.02309‑18 30833427
     [Google Scholar]
  65. AlachkarA. OjhaS.K. SadeqA. Experimental models for the discovery of novel anticonvulsant drugs: Focus on pentylenetetrazole-induced seizures and associated memory deficits.Curr. Pharm. Des.202026151693171110.2174/1381612826666200131105324 32003682
     [Google Scholar]
  66. AllegraA. InnaoV. RussoS. GeraceD. AlonciA. MusolinoC. Anticancer activity of curcumin and its analogues: Preclinical and clinical studies.Cancer Invest.201735112210.1080/07357907.2016.1247166
     [Google Scholar]
  67. PrasadRK Books chemistry and synthesis of medicinal agents: expanding knowledge of drug chemistry2017Available from: https://books.google.co.in/books?id=r6IsDwAAQBAJ&dq=Imidazole+Derivatives+
    [Google Scholar]
  68. DengD.Z. HusariK.S. Approach to patients with seizures and epilepsy: A guide for primary care physicians.Prim. Care202451221123210.1016/j.pop.2024.02.008
     [Google Scholar]
  69. KumarS.P. SherpaD.D. SahuA.K. JadavT. TekadeR.K. SenguptaP. Innovation in bioanalytical strategies and in vitro drug-drug interaction study approaches in drug discovery.Bioanalysis202113651353210.4155/bio‑2021‑0001
     [Google Scholar]
  70. JeyanthiS NarayananS MuniyappanCN Discovery of N-Substituted Pyrazoline derivatives as novel 3- Benzo[b]thiophene and 2- Mercaptobenzimidazole inhibitor for the treatment of breast cancer. Res Squ20231610.21203/rs.3.rs‑3492941/v1
     [Google Scholar]
  71. ChauhanB. KumarR. MazumderA. Updates on the synthetic strategies and structure-activity relationship of anticonvulsant benzothiazole and benzimidazole derivatives.Lett. Drug Des. Discov.202220101458148210.2174/03666220606143616
     [Google Scholar]
  72. DeviS.M. SrinivasanS. MuthuvelA. Biocatalysis and agricultural biotechnology selenium nanomaterial is a promising nanotechnology for biomedical and environmental remediation: A detailed review.Biocatal. Agric. Biotechnol.20235110276610.1016/j.bcab.2023.102766
     [Google Scholar]
  73. HangS. LuH. JiangY. Marine-derived metabolites act as promising antifungal agents.Mar. Drugs202422418010.3390/md22040180
     [Google Scholar]
  74. NaharD. MohiteP. LonkarA. ChidrawarV.R. DodiyaR. UddinM.J. An insight into new strategies and targets to combat antifungal resistance: A comprehensive review.Europ. J. Med. Chem. Rep.20241010012010.1016/j.ejmcr.2023.100120
     [Google Scholar]
  75. Al-KazweenyR. Muhi-EldeenZ.A. Al-KaissiE. Al-TameemiS. TayehS.S. Al-HusseniniJ. Designs, synthesis, structural elucidation and antimicrobial evaluation of various derivatives of 2-mercaptobenzimidazole as possible antimicrobial agents.Int. J. Med. Res. Health Sci.2020202012113
     [Google Scholar]
  76. Al-MahdawiA.S. Al-ObaidiN.S. AhmadA.A. JumaaT.A. AbasZ.A. MahdiH.S. Synthesis, characterization and evaluation biological activity of some 2-mercaptobinzemidazol complexes.Res Chem20251310189310.1016/j.rechem.2024.101893
     [Google Scholar]
  77. PortoR.S. CostaL.F de L. PortoV.A. Identification of synthetic 2-mercaptobenzimidazole derivatives as inhibitors of spike protein of SARS-CoV-2 by virtual screening.Lett App Nano Sci20231221910.33263/LIANBS122.031
     [Google Scholar]
  78. DeviP. ShahnazM. PrasadD.N. Recent overview on synthesis of 2-mercaptobenzimidazole derivatives and its activities.J. Drug Deliv. Ther.202212120320710.22270/jddt.v12i1.5166
     [Google Scholar]
  79. AlkhafajiA. ProfileS. Muhi-EldeenZ.A. Al-KaissiE. Al-MuhtasebN. Synthesis, structural elucidation, and evaluation of antimicrobial activity of 5-ethoxy-2-mercaptobenzimidazole derivatives.Inter J Med Res Health Sci201816
     [Google Scholar]
  80. GuillaumeK EtienneT AdeyoléT SouleymaneC FaustinA SiomenanC Design, synthesis of bisbenzimidazole dithiol derivatives and analogs. Adv Res Rev202213020859010.30574/gscarr.2022.13.2.0300
     [Google Scholar]
  81. ZubairA.M. MalikM.N. YounisW. MalikM.A. JahanS. AhmedI. YuchiA. MushtaqM.N. TahirR. SarwarM.B. RomanM. Malik MA, Jahan S, Ahmed I, Yuchi A, Mushtaq MN, Tahir R, Sarwar MB, Roman M. Novel acetamide derivatives of 2-aminobenzimidazole prevent inflammatory arthritis in rats via suppression of pro-inflammatory mediators.Inflammopharmacology202230310051019
     [Google Scholar]
  82. TahlanS. NarasimhanB. LimS.M. RamasamyK. ManiV. ShahS.A.A. 2-Mercaptobenzimidazole schiff bases: Design, synthesis, antimicrobial studies and anticancer activity on HCT-116 cell line.Mini Rev. Med. Chem.201919131080109210.2174/1389557518666181009151008 30306865
     [Google Scholar]
  83. SuaadM.H.A.M. HalahA.R.I. YasserA.H.A.I. Synthesis and identification of some new derivatives of ([Benzyl Thio) benzimidazole -N- (Methylene-5-Yl)] - 4,5- di substituted 1,2,4-Triazole and evaluation of their activity as antimicrobial and anti-inflammatory agents.Iraqi J. Sci.20216241054106510.24996/ijs.2021.62.4.2
     [Google Scholar]
  84. TurkeyR.H. kubba MAABR, Fadhil AA, AlShawi NN. Synthesis and anti-inflammatory activity of some -5-ethoxy-2- mercapto benzimidazole derivatives.Inter J Current Pharm Rev Res2017811910.25258/ijcprr.v8i01.9084
     [Google Scholar]
  85. Al-WarhiT. SaidM. HassabE.M. Unexpected synthesis, single-crystal x-ray structure, anticancer activity, and molecular docking studies of certain 2–((imidazole/benzimidazol–2–yl)thio)– 1–arylethanones.Crystals202010644610.3390/cryst10060446
     [Google Scholar]
  86. NayagamR.D. VadivelE. RavindranB. NayagamD. DaisyC. VadivelE. Anticancer activity of derivatives of 2-Mercaptobenzimidazole-Molecular docking approach.Pharma Innovat J2018710279283
     [Google Scholar]
  87. AndradeP. DiasF.A. FigueiróF. 1,2,3-Triazole tethered 2-mercaptobenzimidazole derivatives: Design, synthesis and molecular assessment toward C6 glioma cell line.Future Med. Chem.202012868970810.4155/fmc‑2019‑0227 32193951
     [Google Scholar]
  88. KhalifaM.E. Synthesis and evaluation of new 2‐mercaptomethyl benzimidazole scaffolds as potential antibacterial, antioxidant and cytotoxic agents.ChemistrySelect2020534105621056610.1002/slct.202002822
     [Google Scholar]
  89. AliM. AliS. KhanM. Synthesis, biological activities, and molecular docking studies of 2-mercaptobenzimidazole based derivatives.Bioorg. Chem.20188047247910.1016/j.bioorg.2018.06.032 29990895
     [Google Scholar]
  90. Abd El-AllA.S. RagabF.A. Magd El-DinA.A. AbdallaM.M. El-HefnawiM.M. El-RashedyA.A. Design, synthesis and anticancer evaluation of some selected Schiff bases derived from benzimidazole derivative.Glob. J. Pharmacol.20137143152
     [Google Scholar]
  91. ShabbirR. MalikH.M.N. ZaibM. Alamgeer, Jahan S, Khan MT. Amino acid conjugates of 2-mercaptobenzimidazole ameliorates high-fat diet-induced hyperlipidemia in rats via attenuation of HMGCR, APOB, and PCSK9.ACS Omega2022744405024051110.1021/acsomega.2c05735 36385864
     [Google Scholar]
  92. VoroninM.V. KadnikovI.A. ZainullinaL.F. Neuroprotective properties of quinone reductase 2 inhibitor M-11, a 2-mercaptobenzimidazole derivative.Int. J. Mol. Sci.202122231306110.3390/ijms222313061 34884863
     [Google Scholar]
  93. BegumF. RehmanN.U. KhanA. 2-Mercaptobenzimidazole clubbed hydrazone for Alzheimer’s therapy: In vitro, kinetic, in silico, and in vivo potentials.Front. Pharmacol.20221394613410.3389/fphar.2022.946134 36059999
     [Google Scholar]
  94. EbenezerO. Oyetunde-JoshuaF. OmotosoO.D. ShapiM. Benzimidazole and its derivatives: Recent advances (2020–2022).Res Chem2023510092510.1016/j.rechem.2023.100925
     [Google Scholar]
  95. TweedieD. SambamurtiK. GreigN.H. TNF-α inhibition as a treatment strategy for neurodegenerative] disorders: New drug candidates and targets.Curr. Alzheimer Res.20074437838510.2174/156720507781788873
     [Google Scholar]
  96. ImranM. ShahF.A. NadeemH. Synthesis and biological evaluation of benzimidazole derivatives as potential neuroprotective agents in an ethanol-induced rodent model.ACS Chem. Neurosci.202112348950510.1021/acschemneuro.0c00659 33430586
     [Google Scholar]
  97. AlnaaimS.A. Al-kuraishyH.M. Al-GareebA.I. AliN.H. AlexiouA. PapadakisM. New insights on the potential anti-epileptic effect of metformin: Mechanistic pathway.J. Cell. Mol. Med.202327243953396510.1111/jcmm.17965
     [Google Scholar]
  98. RahimF. AzizimalamiriR. SayyahM. MalayeriA. Experimental therapeutic strategies in epilepsies using anti-seizure medications.J. Exp. Pharmacol.20211326529010.2147/JEP.S267029
     [Google Scholar]
  99. KuzmanovaR. StefanovaI. Basic mechanisms of action of the antiepileptic drugs.Acta Med. Bulg.2017442525810.1515/amb‑2017‑0020
     [Google Scholar]
  100. RizoJ. Mechanism of neurotransmitter release coming into focus.Protein Sci.20182781364139110.1002/pro.3445
     [Google Scholar]
  101. JaroszM. OlbertM. WyszogrodzkaG. MłyniecK. LibrowskiT. Antioxidant and anti-inflammatory effects of zinc.Inflammopharmacol201725112410.1007/s10787‑017‑0309‑4
     [Google Scholar]
  102. FarhadiF. KhamenehB. IranshahiM. IranshahyM. Antibacterial activity of flavonoids and their structure–activity relationship: An update review.Phytother. Res.2019331134010.1002/ptr.6208
     [Google Scholar]
  103. ChenG. XuB. LuM. ChenN.S. Exploring blockchain technology and its potential applications for education.Smart Learn Enviro20185111010.1186/s40561‑017‑0050‑x
     [Google Scholar]
  104. BrishtyS.R. HossainM.J. KhandakerM.U. FaruqueM.R.I. OsmanH. RahmanS.M.A. A comprehensive account on recent progress in pharmacological activities of benzimidazole derivatives.Front. Pharm.202112762807
     [Google Scholar]
  105. ShuL.R. YiM.T. LingZ. ChenH.Z. Comprehensive insights into medicinal research on imidazole-based supramolecular complexes.Pharmaceutics2023155134810.3390/pharmaceutics15051348
     [Google Scholar]
/content/journals/biot/10.2174/0118722083345879250403115017
Loading
Exploring the Two-Way Role: Biological and Anti-Epileptic Properties of Imidazole and 2-Mercaptobenzimidazole Derivatives
Recent Pat. Biotechnol. 20, 222 (2026); https://doi.org/10.2174/0118722083345879250403115017
/content/journals/biot/10.2174/0118722083345879250403115017
/content/journals/biot/10.2174/0118722083345879250403115017
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): 2-mercapto benzimidazole; anti-epileptic agent; anti-inflammatory; antifungal; antimicrobial; antioxidant; biological activities; epilepsy; GABA receptors; Imidazole; neuroprotection; seizure

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test